<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Pharmacovigilance</title>
    <subTitle>critique and ways forward</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Edwards, I. Ralph</namePart>
    <role>
      <roleTerm type="text">editor</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Lindquist, Marie</namePart>
    <role>
      <roleTerm type="text">editor</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">sz</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Suiza</placeTerm>
    </place>
    <publisher>Adis</publisher>
    <dateIssued>2017</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <extent>xxxi, 205 páginas</extent>
  </physicalDescription>
  <tableOfContents>1. How to learn Pharmacovigilance, now and in the Future -- 2. Lost in Regulation -- 3. What is the Future of Pharmacovigilance and how can we Make it as Good as Possible? -- 4. Some Other Ideas About the Future of Pharmacovigilance -- 5. Best Safety Practices now and in the Future -- 6. Is There a Benefit from the Medical Literature Monitoring Service of the EMA? -- 7. The Unified Drug Safety-Clinical Database -- 8. Behind the Scenes -- 'Silent Factors' Influencing Pharmacovigilance Practice and Decisions -- 9. Shaking up Culture and Communication in PV [V6] -- 10. Broadening the Scope of Pharmacovigilance -- 11. Effective Treatment Matters: Revitalizing Pharmacoviglance -- 12. There are More Weber-Effects -- 13. Herbal and Traditional Medicines, Now and Future -- 14. The Concept of 'Health' -- 15. Impact of Referral Procedures on the Interaction of RMP and PSUR -- 16. Other Sources of Information for Monitoring Drug Safety: Now and in the Future -- 17. Ecopharmacovigilance.</tableOfContents>
  <note type="statement of responsibility">I. Ralph Edwards, Marie Lindquist, editores</note>
  <subject authority="">
    <topic>Farmacoepidemiología</topic>
  </subject>
  <subject authority="">
    <topic>Drogas</topic>
    <topic>Efectos secundarios</topic>
  </subject>
  <subject authority="">
    <topic>Interacción de drogas</topic>
  </subject>
  <classification authority="nlm">QV 771</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Medicine, General</title>
    </titleInfo>
  </relatedItem>
  <relatedItem type="otherFormat" displayLabel="Printed edition:"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn">9783319403991</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">CO-BoUCM</recordContentSource>
    <recordCreationDate encoding="marc">180315</recordCreationDate>
    <recordChangeDate encoding="iso8601">20180315112543.0</recordChangeDate>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
